BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $668,600 | +23.9% | 94,435 | +23.2% | 0.01% | +16.7% |
| Q2 2023 | $539,700 | -53.9% | 76,662 | -17.5% | 0.01% | -76.0% |
| Q3 2022 | $1,170,000 | +358.8% | 92,879 | +286.0% | 0.02% | +257.1% |
| Q2 2022 | $255,000 | -86.5% | 24,061 | -81.6% | 0.01% | -77.4% |
| Q3 2021 | $1,883,000 | +89.4% | 131,066 | +108.4% | 0.03% | +63.2% |
| Q2 2021 | $994,000 | +68.8% | 62,898 | +8.6% | 0.02% | +58.3% |
| Q1 2021 | $589,000 | +501.0% | 57,917 | +18.0% | 0.01% | +33.3% |
| Q1 2020 | $98,000 | -81.4% | 49,102 | -67.9% | 0.01% | -62.5% |
| Q4 2019 | $528,000 | +212.4% | 153,107 | +158.9% | 0.02% | +300.0% |
| Q3 2019 | $169,000 | +20.7% | 59,148 | +60.4% | 0.01% | +50.0% |
| Q2 2019 | $140,000 | -73.9% | 36,867 | -64.0% | 0.00% | -71.4% |
| Q3 2017 | $537,000 | +130.5% | 102,494 | +144.5% | 0.01% | +100.0% |
| Q2 2017 | $233,000 | +375.5% | 41,928 | +276.5% | 0.01% | +600.0% |
| Q3 2016 | $49,000 | +4.3% | 11,137 | -33.3% | 0.00% | 0.0% |
| Q2 2016 | $47,000 | -86.8% | 16,687 | -86.7% | 0.00% | -88.9% |
| Q1 2016 | $355,000 | +208.7% | 125,588 | +1022.8% | 0.01% | +200.0% |
| Q4 2015 | $115,000 | -65.9% | 11,185 | -62.1% | 0.00% | -72.7% |
| Q3 2015 | $337,000 | +69.3% | 29,535 | +121.9% | 0.01% | +83.3% |
| Q2 2015 | $199,000 | – | 13,308 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |